A panelist discusses how recent advances in transurethral resection of bladder tumor (TURBT) include enhanced visualization techniques like fluorescence-guided surgery and narrow-band imaging to ...
"I think that it's so important right now to really, really stand as your own brand and really, really have a cultivated patient population that you're after," says Gia Ching. In this video, Amy M.
"We are now in the golden era of BPH/BPO for both diagnostics and therapeutics," says Wayne Kuang, MD. In this video, Wayne Kuang, MD, shares his thoughts on what advances in benign prostatic ...
Erdafitinib received full FDA approval for FGFR3-positive urothelial carcinoma, demonstrating improved overall survival in the phase 3 THOR trial. Cefepime ...
"We also need to understand and remember that drugs are temporizing measures," says Wayne Kuang, MD. In this video, Wayne Kuang, MD, discusses key factors health care professionals should consider ...
Quiz: What CUA guidelines say about genomic profiling of tumors in prostate cancer ...
Quiz: What CUA guidelines say about genomic profiling of tumors in prostate cancer ...
"We...tried to summarize all the findings that could potentially be helpful for future research in terms of bladder cancer," says Ilaha Isali, MD, MSc. Isali ...
Lenvatinib/pembrolizumab and nivolumab/cabozantinib show improved survival and response rates in advanced renal cell carcinoma. Machine learning and surgical algorithms are advancing personalized ...
"When I eventually met Das at an AUA annual meeting, his smile and demeanor were captivating. I had to push through the hordes of admirers to get close to him," writes Gopal H. Badlani, MD. Sakti Das, ...
A race coefficient improves 4Kscore calibration for Black men, enhancing prostate cancer risk assessment accuracy. Increasing diversity in clinical trials is crucial for more representative prostate ...
TLX250-CDx aims to address unmet needs in ccRCC imaging, with a potential U.S. commercial launch in 2025. The FDA's initial concerns were related to sterility assurance, not the agent's safety or ...